Equifax (EFX) Competitors $237.50 +3.47 (+1.48%) Closing price 09/3/2025 03:59 PM EasternExtended Trading$236.60 -0.90 (-0.38%) As of 09/3/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EFX vs. CCRN, CRAI, APTV, FI, G, IQV, OMC, RHI, TRU, and WMShould you be buying Equifax stock or one of its competitors? The main competitors of Equifax include Cross Country Healthcare (CCRN), Charles River Associates (CRAI), Aptiv (APTV), Fiserv (FI), Genpact (G), IQVIA (IQV), Omnicom Group (OMC), Robert Half (RHI), TransUnion (TRU), and Waste Management (WM). Equifax vs. Its Competitors Cross Country Healthcare Charles River Associates Aptiv Fiserv Genpact IQVIA Omnicom Group Robert Half TransUnion Waste Management Cross Country Healthcare (NASDAQ:CCRN) and Equifax (NYSE:EFX) are both business services companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability. Do institutionals and insiders believe in CCRN or EFX? 96.0% of Cross Country Healthcare shares are held by institutional investors. Comparatively, 96.2% of Equifax shares are held by institutional investors. 4.9% of Cross Country Healthcare shares are held by company insiders. Comparatively, 1.4% of Equifax shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk and volatility, CCRN or EFX? Cross Country Healthcare has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500. Comparatively, Equifax has a beta of 1.68, indicating that its stock price is 68% more volatile than the S&P 500. Does the media refer more to CCRN or EFX? In the previous week, Equifax had 13 more articles in the media than Cross Country Healthcare. MarketBeat recorded 23 mentions for Equifax and 10 mentions for Cross Country Healthcare. Cross Country Healthcare's average media sentiment score of 1.48 beat Equifax's score of 1.20 indicating that Cross Country Healthcare is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cross Country Healthcare 9 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Equifax 14 Very Positive mention(s) 1 Positive mention(s) 8 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has preferable earnings and valuation, CCRN or EFX? Equifax has higher revenue and earnings than Cross Country Healthcare. Cross Country Healthcare is trading at a lower price-to-earnings ratio than Equifax, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCross Country Healthcare$1.34B0.31-$14.56M-$0.26-49.27Equifax$5.68B5.18$604.10M$5.1146.48 Is CCRN or EFX more profitable? Equifax has a net margin of 10.95% compared to Cross Country Healthcare's net margin of -0.70%. Equifax's return on equity of 18.89% beat Cross Country Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Cross Country Healthcare-0.70% 1.72% 1.24% Equifax 10.95%18.89%7.84% Do analysts recommend CCRN or EFX? Cross Country Healthcare currently has a consensus price target of $17.93, suggesting a potential upside of 39.97%. Equifax has a consensus price target of $283.53, suggesting a potential upside of 19.38%. Given Cross Country Healthcare's higher possible upside, analysts plainly believe Cross Country Healthcare is more favorable than Equifax.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cross Country Healthcare 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Equifax 0 Sell rating(s) 6 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.74 SummaryEquifax beats Cross Country Healthcare on 14 of the 17 factors compared between the two stocks. Get Equifax News Delivered to You Automatically Sign up to receive the latest news and ratings for EFX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EFX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EFX vs. The Competition Export to ExcelMetricEquifaxConsulting IndustryBusiness SectorNYSE ExchangeMarket Cap$30.49B$6.78B$26.48B$21.39BDividend Yield0.81%1.70%2.74%3.49%P/E Ratio46.4823.2526.9129.08Price / Sales5.182.551,061.9548.95Price / Cash19.1916.8425.6318.29Price / Book5.745.236.175.30Net Income$604.10M$272.15M$198.30M$998.51M7 Day Performance-2.57%-2.29%-0.74%-0.63%1 Month Performance-2.43%-2.21%8.05%4.90%1 Year Performance-21.47%-9.04%50.81%13.95% Equifax Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EFXEquifax4.8889 of 5 stars$237.50+1.5%$283.53+19.4%-21.5%$30.49B$5.68B46.4814,700News CoveragePositive NewsCCRNCross Country Healthcare3.7392 of 5 stars$13.38+0.1%$17.93+34.0%-12.4%$438.33M$1.34B-51.468,205Positive NewsCRAICharles River Associates3.4117 of 5 stars$193.76-1.1%$228.00+17.7%+19.3%$1.28B$712.91M23.46940Positive NewsAPTVAptiv4.2328 of 5 stars$79.68-0.8%$81.81+2.7%+13.6%$17.35B$19.71B18.23141,000News CoveragePositive NewsAnalyst ForecastFIFiserv4.9805 of 5 stars$138.09+0.3%$207.36+50.2%-21.3%$75.07B$383.42M23.0538,000Trending NewsGGenpact3.6484 of 5 stars$45.33+0.8%$52.29+15.3%+16.5%$7.90B$4.77B15.06140,000Positive NewsIQVIQVIA4.8976 of 5 stars$190.71+1.0%$228.62+19.9%-26.0%$32.42B$15.70B27.6088,000Positive NewsAnalyst ForecastOMCOmnicom Group4.4363 of 5 stars$78.34+0.8%$94.43+20.5%-22.1%$15.18B$15.91B11.2474,900Positive NewsRHIRobert Half4.6631 of 5 stars$37.37+2.3%$45.83+22.7%-39.5%$3.80B$5.80B21.3514,700Positive NewsTRUTransUnion4.8947 of 5 stars$88.41-0.3%$112.46+27.2%-9.0%$17.22B$4.18B44.2113,400Trending NewsAnalyst UpgradeWMWaste Management4.836 of 5 stars$226.69+0.9%$254.35+12.2%+7.1%$91.32B$22.06B33.6361,700 Related Companies and Tools Related Companies Cross Country Healthcare Alternatives Charles River Associates Alternatives Aptiv Alternatives Fiserv Alternatives Genpact Alternatives IQVIA Alternatives Omnicom Group Alternatives Robert Half Alternatives TransUnion Alternatives Waste Management Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:EFX) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Equifax, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Equifax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
